Bionomics Ltd Adr Stock Cash And Equivalents

BNOX Stock

USD 0.30 0.02 7.14%

Bionomics Ltd ADR fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Stock. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bionomics Ltd ADR Company Cash And Equivalents Analysis

Bionomics' Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current Bionomics Cash And Equivalents

33.56 M

Most of Bionomics' fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bionomics Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for Bionomics is extremely important. It helps to project a fair market value of Bionomics Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Bionomics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bionomics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bionomics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Investments	Net Tangible Assets	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Capital Stock
Total Assets		0.77	-0.45	0.05	0.6	0.73	0.97	0.41	0.2	0.38	0.87	0.3	0.69	0.37	-0.18	0.45	0.37	0.27	0.28	0.38	0.43	0.19
Total Stockholder Equity	0.77		-0.78	-0.02	0.42	0.12	0.8	-0.16	0.36	0.51	0.65	0.57	0.41	0.07	0.24	0.2	0.56	-0.1	-0.12	0.59	0.11	0.3
Net Debt	-0.45	-0.78		0.18	-0.25	0.12	-0.58	0.38	-0.44	-0.04	-0.22	-0.41	-0.08	0.24	-0.5	-0.06	-0.48	0.42	0.43	-0.63	0.13	-0.11
Retained Earnings	0.05	-0.02	0.18		0.0	0.07	0.08	0.16	-0.94	0.16	0.09	0.23	-0.35	0.71	-0.58	0.75	0.38	0.76	0.72	0.35	0.81	0.43
Accounts Payable	0.6	0.42	-0.25	0.0		0.48	0.57	0.14	0.14	0.22	0.71	0.13	0.17	0.21	-0.33	0.52	-0.08	0.25	0.23	0.11	0.4	-0.18
Total Liab	0.73	0.12	0.12	0.07	0.48		0.65	0.8	-0.05	0.04	0.66	-0.13	0.63	0.48	-0.52	0.47	-0.05	0.51	0.54	-0.05	0.53	-0.06
Total Current Assets	0.97	0.8	-0.58	0.08	0.57	0.65		0.29	0.17	0.39	0.76	0.4	0.57	0.32	-0.12	0.51	0.42	0.21	0.23	0.5	0.44	0.14
Short Term Debt	0.41	-0.16	0.38	0.16	0.14	0.8	0.29		-0.23	-0.17	0.41	-0.28	0.5	0.53	-0.54	0.28	-0.09	0.6	0.64	-0.21	0.47	0.08
Common Stock	0.2	0.36	-0.44	-0.94	0.14	-0.05	0.17	-0.23		0.03	0.13	-0.01	0.45	-0.65	0.63	-0.63	-0.16	-0.75	-0.72	-0.13	-0.73	-0.3
Net Receivables	0.38	0.51	-0.04	0.16	0.22	0.04	0.39	-0.17	0.03		0.37	0.61	0.25	0.11	-0.03	0.2	0.21	0.11	0.1	0.24	0.18	0.12
Intangible Assets	0.87	0.65	-0.22	0.09	0.71	0.66	0.76	0.41	0.13	0.37		0.21	0.56	0.45	-0.34	0.42	0.17	0.39	0.39	0.14	0.43	0.14
Current Deferred Revenue	0.3	0.57	-0.41	0.23	0.13	-0.13	0.4	-0.28	-0.01	0.61	0.21		-0.05	0.0	0.08	0.24	0.3	-0.07	0.03	0.39	0.22	0.1
Good Will	0.69	0.41	-0.08	-0.35	0.17	0.63	0.57	0.5	0.45	0.25	0.56	-0.05		0.09	0.11	-0.16	0.19	-0.03	-0.02	0.06	-0.08	0.28
Short Term Investments	0.37	0.07	0.24	0.71	0.21	0.48	0.32	0.53	-0.65	0.11	0.45	0.0	0.09		-0.72	0.68	0.14	0.85	0.83	0.06	0.82	0.22
Net Tangible Assets	-0.18	0.24	-0.5	-0.58	-0.33	-0.52	-0.12	-0.54	0.63	-0.03	-0.34	0.08	0.11	-0.72		-0.71	0.36	-0.9	-0.88	0.38	-0.78	0.12
Long Term Debt	0.45	0.2	-0.06	0.75	0.52	0.47	0.51	0.28	-0.63	0.2	0.42	0.24	-0.16	0.68	-0.71		0.21	0.74	0.72	0.33	0.92	0.07
Net Invested Capital	0.37	0.56	-0.48	0.38	-0.08	-0.05	0.42	-0.09	-0.16	0.21	0.17	0.3	0.19	0.14	0.36	0.21		-0.02	0.0	0.92	0.22	0.7
Long Term Investments	0.27	-0.1	0.42	0.76	0.25	0.51	0.21	0.6	-0.75	0.11	0.39	-0.07	-0.03	0.85	-0.9	0.74	-0.02		0.96	-0.09	0.87	0.18
Short Long Term Debt	0.28	-0.12	0.43	0.72	0.23	0.54	0.23	0.64	-0.72	0.1	0.39	0.03	-0.02	0.83	-0.88	0.72	0.0	0.96		-0.07	0.9	0.14
Net Working Capital	0.38	0.59	-0.63	0.35	0.11	-0.05	0.5	-0.21	-0.13	0.24	0.14	0.39	0.06	0.06	0.38	0.33	0.92	-0.09	-0.07		0.26	0.55
Property Plant Equipment	0.43	0.11	0.13	0.81	0.4	0.53	0.44	0.47	-0.73	0.18	0.43	0.22	-0.08	0.82	-0.78	0.92	0.22	0.87	0.9	0.26		0.19
Capital Stock	0.19	0.3	-0.11	0.43	-0.18	-0.06	0.14	0.08	-0.3	0.12	0.14	0.1	0.28	0.22	0.12	0.07	0.7	0.18	0.14	0.55	0.19

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict Bionomics

In accordance with the recently published financial statements, Bionomics Ltd ADR has 33.56 M in Cash And Equivalents. This is 95.91% lower than that of the Biotechnology sector and 92.49% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.76% higher than that of the company.

Bionomics Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.

Bionomics is currently under evaluation in cash and equivalents category among its peers.

Bionomics Fundamentals

	Return On Equity	-0.78
	Return On Asset	-0.4
	Operating Margin	89.10 %
	Current Valuation	(1.97 M)
	Shares Outstanding	19.53 M
	Shares Owned By Insiders	33.91 %
	Shares Owned By Institutions	16.22 %
	Number Of Shares Shorted	384.28 K
	Price To Book	0.34 X
	Price To Sales	386.72 X
	Revenue	20 K
	Gross Profit	(18.96 M)
	EBITDA	(9.84 M)
	Net Income	(15.49 M)
	Cash And Equivalents	33.56 M
	Cash Per Share	4.46 X
	Total Debt	272.74 K
	Debt To Equity	0.01 %
	Current Ratio	12.46 X
	Book Value Per Share	1.32 X
	Cash Flow From Operations	(14.68 M)
	Short Ratio	0.13 X
	Earnings Per Share	(1.19) X
	Target Price	15.37
	Beta	-0.069
	Market Capitalization	5.86 M
	Total Asset	18.96 M
	Retained Earnings	(177.98 M)
	Working Capital	9.36 M
	Net Asset	18.96 M

About Bionomics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC